Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus topical lidocaine for esophagogastroduodenoscopy sedation support
IRCT20231107059983N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: lidocaine in endoscopy. Started Apr 2024; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on IRCT20231107059983N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231107059983N1.